Mercodia has announced the appointment of Jörgen Dahlström as new Chief Executive Officer.
Dahlström holds a PhD in immunology and has held several different management positions at a number of international life science companies over the last 20 years. He will become the 3rd CEO in the company’s 30-year history.
“Mercodia is a very exciting company, with several untapped opportunities to expand its business, both by market expansion, strategic partnerships, and innovation. I am excited and honored to take on the role to lead the company into the future,” says JörgenDahlström.
Marks a new direction
The recruitment of Jörgen Dahlström as CEO marks a new direction for Mercodia, and the company will expand the portfolio of products and services beyond what the company is offering today.
“I want to unleash the full power of Mercodia’s capacity to become an important player in the life science industry globally. I want the company to be viewed as the natural partner for start-ups and smaller companies who seek a business partner that can help develop and commercialize their products and services. In this way Mercodia and the partners can drive innovation faster and together create a stronger position for providing solutions improving the health and clinical outcome of patients,” concludes Jörgen Dahlström.
Photo of Jörgen Dahlström: mercodia.com
